BR112014002960A2 - inibição de canal de íons potencial receptor transiente trpa1 - Google Patents
inibição de canal de íons potencial receptor transiente trpa1Info
- Publication number
- BR112014002960A2 BR112014002960A2 BR112014002960A BR112014002960A BR112014002960A2 BR 112014002960 A2 BR112014002960 A2 BR 112014002960A2 BR 112014002960 A BR112014002960 A BR 112014002960A BR 112014002960 A BR112014002960 A BR 112014002960A BR 112014002960 A2 BR112014002960 A2 BR 112014002960A2
- Authority
- BR
- Brazil
- Prior art keywords
- trpa1
- ion channel
- transient receptor
- receptor potential
- channel inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
abstract this disclosure describes a novel compounds and pharmaceutical compositions for inhibiting the trpa1 ion channel and/or medical conditions related to trpa1, such as pain or asthma. tradução do resumo resumo patente de invenção: "inibição de canal de íons potencial re-ceptor transiente trpa1". a presente invenção descreve novos compostos e composições farmacêuticas para inibir o canal de íons trpa1 e/ou condições médicas relativas a trpa1, tal como dor ou asma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161521705P | 2011-08-09 | 2011-08-09 | |
PCT/US2012/050210 WO2013023102A1 (en) | 2011-08-09 | 2012-08-09 | Inhibiting transient receptor potential ion channel trpa1 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014002960A2 true BR112014002960A2 (pt) | 2017-02-21 |
Family
ID=46717941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014002960A BR112014002960A2 (pt) | 2011-08-09 | 2012-08-09 | inibição de canal de íons potencial receptor transiente trpa1 |
Country Status (13)
Country | Link |
---|---|
US (1) | US9193729B2 (pt) |
EP (1) | EP2742048B1 (pt) |
JP (1) | JP2014521724A (pt) |
KR (1) | KR20140073496A (pt) |
CN (1) | CN103265543A (pt) |
AR (1) | AR087501A1 (pt) |
AU (1) | AU2012294300A1 (pt) |
BR (1) | BR112014002960A2 (pt) |
CA (1) | CA2843965A1 (pt) |
MX (1) | MX2014001551A (pt) |
RU (1) | RU2014108885A (pt) |
TW (1) | TW201311690A (pt) |
WO (1) | WO2013023102A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2014108885A (ru) | 2011-08-09 | 2015-09-20 | Хайдра Байосайенсиз, Инк. | Ингибирование транзиторного рецепторного потенциала ионного канала trpa1 |
CN104203236A (zh) | 2012-01-17 | 2014-12-10 | 味之素株式会社 | 杂环酰胺衍生物和含有其的药物 |
WO2014026073A1 (en) * | 2012-08-09 | 2014-02-13 | Cubist Pharmaceuticals, Inc. | Compositions with increased stability for inhibiting transient receptor potential ion channel trpa1 |
US9394308B2 (en) | 2013-01-18 | 2016-07-19 | Merck Sharp & Dohme Corp. | Inhibiting the transient receptor potential A1 ion channel |
EP2945947B1 (en) | 2013-01-18 | 2019-12-04 | Merck Sharp & Dohme Corp. | Inhibiting the transient receptor potential a1 ion channel |
NZ711718A (en) * | 2013-03-15 | 2020-05-29 | Hydra Biosciences Llc | Substituted xanthines and methods of use thereof |
GB201309333D0 (en) * | 2013-05-23 | 2013-07-10 | Agency Science Tech & Res | Purine diones as WNT pathway modulators |
TWI676626B (zh) | 2014-04-23 | 2019-11-11 | 美商美國禮來大藥廠 | 抑制瞬時受體電位a1離子通道 |
CN106715430B (zh) | 2014-09-19 | 2019-09-17 | 伊莱利利公司 | 抑制瞬时型感受器电位a1离子通道 |
WO2017060488A1 (en) | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
WO2017064068A1 (en) | 2015-10-14 | 2017-04-20 | Almirall, S.A. | New trpa1 antagonists |
WO2018109155A1 (en) | 2016-12-16 | 2018-06-21 | Galderma Research & Development | Trpa1 antagonists for use in the treatment of atopic dermatitis |
US11161849B2 (en) * | 2018-01-31 | 2021-11-02 | Eli Lilly And Company | Inhibiting the transient receptor potential al ion channel |
IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1708703A4 (en) | 2003-12-11 | 2008-04-09 | Anormed Inc | CHEMOKIN RECEPTOR BINDING COMPOUNDS |
WO2005065050A2 (ja) | 2003-12-25 | 2005-07-21 | Asahi Kasei Pharma Corporation | 2環化合物 |
US20070016283A1 (en) | 2005-06-28 | 2007-01-18 | Stout Medical Group, Inc. | Micro-thin film structures for cardiovascular indications |
DE102005054610B4 (de) | 2005-11-08 | 2010-06-10 | Awd.Pharma Gmbh & Co. Kg | Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung |
EP1962855B1 (en) * | 2005-12-22 | 2013-08-21 | Hydra Biosciences, Inc. | Trpa1 inhibitors for treating pain |
SI3184527T1 (sl) * | 2007-06-22 | 2020-03-31 | Eli Lilly And Company | Spojine 2,6-diokso,-2,3-dihidro-1H-purina uporabne za zdravljenje stanj povezanih z aktivnostjo TRPA1 kanala |
WO2009144548A1 (en) | 2008-05-28 | 2009-12-03 | Glenmark Pharmaceuticals S.A. | Imidazo [2,1-b] purine derivatives as trpa1 modulators |
WO2009152261A1 (en) | 2008-06-10 | 2009-12-17 | Brandeis University | Methods of insect control by inhibiting or modulating the trpa1 ion gated channel or family members |
US7951814B2 (en) | 2008-06-17 | 2011-05-31 | Glenmark Pharmaceuticals, S.A. | Quinazolinedione derivatives as TRPA1 modulators |
US8362025B2 (en) | 2008-12-22 | 2013-01-29 | Hydra Biosciences, Inc. | Compositions useful for treating disorders related to TRPA1 |
PE20120774A1 (es) | 2009-03-23 | 2012-06-27 | Glenmark Pharmaceuticals Sa | COMPUESTOS DERIVADOS DE PIRAZOLO[3,4-d]PIRIMIDINDIONA COMO MODULADORES DE TRPA1 |
WO2010138879A1 (en) * | 2009-05-29 | 2010-12-02 | Hydra Biosciences, Inc. | Compounds useful for treating disorders related to trpa1 |
WO2010141805A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of trpa1 |
US8829196B2 (en) | 2009-10-07 | 2014-09-09 | Merck Sharp & Dohme Corp. | TRPA1 antagonists |
WO2011114184A1 (en) | 2010-03-15 | 2011-09-22 | Glenmark Pharmaceuticals S.A. | Amides of heterocyclic compounds as trpa1 inhibitors |
EP2627329B1 (en) | 2010-10-12 | 2015-07-08 | AstraZeneca AB | Trpa1 receptor antagonist |
AU2011346763B2 (en) | 2010-12-20 | 2016-01-07 | Glenmark Pharmaceuticals S.A. | 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
RU2014100744A (ru) | 2011-06-13 | 2015-07-20 | Гленмарк Фармасьютикалс С.А. | Лечение респираторных нарушений с помощью trpa1 антагонистов |
RU2014108885A (ru) | 2011-08-09 | 2015-09-20 | Хайдра Байосайенсиз, Инк. | Ингибирование транзиторного рецепторного потенциала ионного канала trpa1 |
US20140158116A1 (en) | 2012-08-09 | 2014-06-12 | Cubist Pharmaceuticals, Inc. | Inhibiting trpa1 for the treatment of asthma |
WO2014026073A1 (en) | 2012-08-09 | 2014-02-13 | Cubist Pharmaceuticals, Inc. | Compositions with increased stability for inhibiting transient receptor potential ion channel trpa1 |
EP2945947B1 (en) | 2013-01-18 | 2019-12-04 | Merck Sharp & Dohme Corp. | Inhibiting the transient receptor potential a1 ion channel |
US9394308B2 (en) | 2013-01-18 | 2016-07-19 | Merck Sharp & Dohme Corp. | Inhibiting the transient receptor potential A1 ion channel |
-
2012
- 2012-08-09 RU RU2014108885/04A patent/RU2014108885A/ru not_active Application Discontinuation
- 2012-08-09 JP JP2014525157A patent/JP2014521724A/ja active Pending
- 2012-08-09 CA CA2843965A patent/CA2843965A1/en not_active Abandoned
- 2012-08-09 AU AU2012294300A patent/AU2012294300A1/en not_active Abandoned
- 2012-08-09 EP EP12748815.3A patent/EP2742048B1/en active Active
- 2012-08-09 BR BR112014002960A patent/BR112014002960A2/pt not_active Application Discontinuation
- 2012-08-09 KR KR1020147005578A patent/KR20140073496A/ko not_active Application Discontinuation
- 2012-08-09 CN CN201210430444XA patent/CN103265543A/zh active Pending
- 2012-08-09 WO PCT/US2012/050210 patent/WO2013023102A1/en active Application Filing
- 2012-08-09 MX MX2014001551A patent/MX2014001551A/es unknown
- 2012-08-09 AR ARP120102918A patent/AR087501A1/es unknown
- 2012-08-09 TW TW101128891A patent/TW201311690A/zh unknown
-
2013
- 2013-03-15 US US13/832,240 patent/US9193729B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2013023102A1 (en) | 2013-02-14 |
KR20140073496A (ko) | 2014-06-16 |
TW201311690A (zh) | 2013-03-16 |
CA2843965A1 (en) | 2013-02-14 |
EP2742048A1 (en) | 2014-06-18 |
US9193729B2 (en) | 2015-11-24 |
AU2012294300A1 (en) | 2014-03-20 |
MX2014001551A (es) | 2014-09-15 |
CN103265543A (zh) | 2013-08-28 |
JP2014521724A (ja) | 2014-08-28 |
RU2014108885A (ru) | 2015-09-20 |
AR087501A1 (es) | 2014-03-26 |
US20130274273A1 (en) | 2013-10-17 |
EP2742048B1 (en) | 2016-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014002960A2 (pt) | inibição de canal de íons potencial receptor transiente trpa1 | |
MD20150043A2 (ro) | Inhibitori ai histon-demetilazelor | |
BR112014021531A8 (pt) | composto, composição farmacêutica e usos dos mesmos | |
ECSP13013068A (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2 | |
ECSP13013024A (es) | 1,3-oxazinas como inhibidores de bace1 y/o bace2 | |
BR112013005141A2 (pt) | diazetidinil diamida como inibidores de monoacilglicerol lipase | |
BR112015009942A2 (pt) | derivados de tiofeno fundidos tricíclicos como inibidores de jak | |
MX2020012825A (es) | Compuestos multiciclicos y metodos de uso de los mismos. | |
UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
TR201902788T4 (tr) | Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri. | |
MX367623B (es) | 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3. | |
MD4436B1 (ro) | Compuşi pentru tratamentul dependenţei | |
BR112014000792A2 (pt) | compostos de piperidinila para uso como inibidores da tanquirase | |
PH12015502365B1 (en) | Bace1 inhibitors | |
IN2014MN01982A (pt) | ||
BR112012032248A2 (pt) | composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina | |
MX337849B (es) | Composiciones y metodos para inhibicion de la via jak. | |
MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
WO2013040227A3 (en) | Therapeutic compounds | |
BR112014001908A2 (pt) | derivados aza heterocíclicos substituídos | |
MX362879B (es) | Usos novedosos. | |
IN2014MN02056A (pt) | ||
BR112017008103A2 (pt) | composto, composição farmacêutica, métodos para tratar uma doença e uma condição, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo e de um segundo agente ativo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |